# NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study

> **NCT06956703** · — · RECRUITING · sponsor: **University of Nottingham** · enrollment: 240 (estimated)

## Conditions studied

- Gastro-Intestinal Disorder
- Crohn Disease
- Ulcerative Colitis
- Inflammatory Bowel Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06956703
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-12
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-02-28
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06956703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06956703, "NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06956703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*